BiopharmaTrend.com

A fresh viewpoint on drug discovery, pharma, and biotech

Subscribe | Become an author | Author LogIn

Website

Contact us at info@biopharmatrend.com to request profile updates/corrections. You must be an official company representative to do so (only requests from corporate emails are accepted).

TwoXAR

About

The convergence of big data, cloud computing, and artificial intelligence has allowed twoXAR to build a drug discovery platform that is order of magnitudes faster, cheaper, and more accurate than traditional wet-lab based approaches.

twoXAR leverages its technology internally to build its own pipeline of therapeutic candidates across diseases as well as collaborate with biotechnology and pharmaceutical companies to jointly discover and develop novel drug candidates by:

- Screening compound libraries for efficacy against a disease or list of diseases
- Screening compound libraries for efficacy against a disease or list of diseases
- Identifying biologic targets from the elucidation of novel biology

Year Founded
2014
Geography
United States of America based
Funding
$14.3 M
Field/area focus
Biology
Research papers
1
Therapeutic focus
  • Dermatology
Product type
  • various
Research Use Case
  • Target identification/validation
Business model
  • contract research

Industry Partnerships

YearPartnerFocus
2017Santen Pharmaceutical

Posts Mentioning This Company

How Big Pharma Adopts AI To Boost Drug Discovery - Oct. 8, 2018
Biopharma Insights